These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25760564)

  • 1. No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants.
    Ericson JE; Thaden J; Cross HR; Clark RH; Fowler VG; Benjamin DK; Cohen-Wolkowiez M; Hornik CP; Smith PB;
    Pediatr Infect Dis J; 2015 Apr; 34(4):371-5. PubMed ID: 25760564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants.
    Thaden JT; Ericson JE; Cross H; Bergin SP; Messina JA; Fowler VG; Benjamin DK; Clark RH; Hornik CP; Smith PB;
    Pediatr Infect Dis J; 2015 Nov; 34(11):1175-9. PubMed ID: 26222060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of linezolid versus vancomycin as definitive antibiotic therapy for heterogeneously resistant vancomycin-intermediate coagulase-negative staphylococcal central-line-associated bloodstream infections in a neonatal intensive care unit.
    Blanchard AC; Fortin E; Laferrière C; Goyer I; Moussa A; Autmizguine J; Quach C
    J Antimicrob Chemother; 2017 Jun; 72(6):1812-1817. PubMed ID: 28333257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Impact of Vancomycin MIC on Outcomes in Patients With Coagulase-negative Staphylococcal Bacteremia.
    Wheat W; Simiyu B; Andonie G; Bellfi L
    Clin Ther; 2024 Jun; 46(6):444-450. PubMed ID: 38493003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of vancomycin treatment for coagulase-negative Staphylococcus sepsis in very low birth weight infants.
    Linder N; Lubin D; Hernandez A; Amit L; Ashkenazi S
    Br J Clin Pharmacol; 2013 Jul; 76(1):58-64. PubMed ID: 23210694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloxacillin versus vancomycin for presumed late-onset sepsis in the Neonatal Intensive Care Unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study.
    Lawrence SL; Roth V; Slinger R; Toye B; Gaboury I; Lemyre B
    BMC Pediatr; 2005 Dec; 5():49. PubMed ID: 16375769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.
    Mashaly GE; El-Mahdy RH
    Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):63. PubMed ID: 28927452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy.
    Bergin SP; Thaden JT; Ericson JE; Cross H; Messina J; Clark RH; Fowler VG; Benjamin DK; Hornik CP; Smith PB;
    Pediatr Infect Dis J; 2015 Sep; 34(9):933-6. PubMed ID: 26065862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of rifampin in persistent coagulase negative staphylococcal bacteremia in neonates.
    van der Lugt NM; Steggerda SJ; Walther FJ
    BMC Pediatr; 2010 Nov; 10():84. PubMed ID: 21092087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The species distribution, antimicrobial resistance and risk factors for poor outcome of coagulase-negative staphylococci bacteraemia in China.
    Cui J; Liang Z; Mo Z; Zhang J
    Antimicrob Resist Infect Control; 2019; 8():65. PubMed ID: 31044070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of antimicrobial stewardship intervention on coagulase-negative Staphylococcus blood cultures in conjunction with rapid diagnostic testing.
    Nagel JL; Huang AM; Kunapuli A; Gandhi TN; Washer LL; Lassiter J; Patel T; Newton DW
    J Clin Microbiol; 2014 Aug; 52(8):2849-54. PubMed ID: 24871213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Validity of Positive Coagulase-Negative Staphylococcus Cultures for the Diagnosis of Sepsis in the Neonatal Unit.
    Benenson S; Cohen MJ; Greenglick N; Schwartz C; Eventov-Friedman S; Ergaz Z
    Am J Perinatol; 2024 Jul; 41(9):1245-1250. PubMed ID: 35381607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors associated with 30-day in-hospital mortality in coagulase-negative Staphylococcus bacteraemia: no impact of vancomycin minimum inhibitory concentration.
    Hentzien M; Strady C; Vernet-Garnier V; Servettaz A; De Champs C; Delmer A; Bani-Sadr F; N'Guyen Y
    Infect Dis (Lond); 2017 Sep; 49(9):664-673. PubMed ID: 28490261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro effect of vancomycin and daptomycin on biofilm formation of coagulase-negative staphylococci strains].
    Öcal DN; Dolapçı İ; Gençtürk Z; Tekeli A
    Mikrobiyol Bul; 2017 Jul; 51(3):220-235. PubMed ID: 28929959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methicillin-resistant
    Peixoto PB; Massinhani FH; Netto Dos Santos KR; Chamon RC; Silva RB; Lopes Correa FE; Barata Oliveira CDCH; Oliveira AG
    J Med Microbiol; 2020 Jan; 69(1):41-45. PubMed ID: 31789588
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination of vancomycin and rifampicin for the treatment of persistent coagulase-negative staphylococcal bacteremia in preterm neonates.
    Rodriguez-Guerineau L; Salvia-Roigés MD; León-Lozano M; Rodríguez-Miguélez JM; Figueras-Aloy J
    Eur J Pediatr; 2013 May; 172(5):693-7. PubMed ID: 23328960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.
    Krediet TG; Jones ME; Gerards LJ; Fleer A
    Pediatrics; 1999 Mar; 103(3):E29. PubMed ID: 10049985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vancomycin in coagulase negative Staphylococcus bacteremia and survival in newborns].
    Delpiano L
    Rev Chilena Infectol; 2015 Jun; 32(3):367. PubMed ID: 26230450
    [No Abstract]   [Full Text] [Related]  

  • 19. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.
    Joo J; Yamaki J; Lou M; Hshieh S; Chu T; Shriner KA; Wong-Beringer A
    Clin Ther; 2013 Jul; 35(7):995-1004. PubMed ID: 23829982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulase-negative staphylococcal bloodstream infections: Does vancomycin remain appropriate empiric therapy?
    Valencia-Rey P; Weinberg J; Miller NS; Barlam TF
    J Infect; 2015 Jul; 71(1):53-60. PubMed ID: 25725152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.